These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 3501355
1. Enzyme immunoassays for the detection of IgG and IgM anti-dsDNA antibodies: clinical significance and specificity. Tzioufas AG, Manoussakis MN, Drosos AA, Silis G, Gharavi AE, Moutsopoulos HM. Clin Exp Rheumatol; 1987; 5(3):247-53. PubMed ID: 3501355 [Abstract] [Full Text] [Related]
2. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjögren's syndrome and rheumatoid arthritis. Karsh J, Halbert SP, Anken M, Klima E, Steinberg AD. Int Arch Allergy Appl Immunol; 1982; 68(1):60-9. PubMed ID: 6978853 [Abstract] [Full Text] [Related]
4. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus. Krippner H, Springer B, Merle S, Pirlet K. Clin Exp Immunol; 1984 Oct; 58(1):49-56. PubMed ID: 6332696 [Abstract] [Full Text] [Related]
5. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Förger F, Matthias T, Oppermann M, Becker H, Helmke K. Lupus; 2004 Oct; 13(1):36-44. PubMed ID: 14870916 [Abstract] [Full Text] [Related]
6. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3. Flechsig A, Rose T, Barkhudarova F, Strauss R, Klotsche J, Dähnrich C, Schlumberger W, Enghard P, Burmester GR, Hiepe F, Biesen R. Clin Exp Rheumatol; 2017 Oct; 35(4):598-606. PubMed ID: 28281463 [Abstract] [Full Text] [Related]
8. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test. Werle E, Blazek M, Fiehn W. Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405 [Abstract] [Full Text] [Related]
13. The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation. Bootsma H, Spronk PE, Ter Borg EJ, Hummel EJ, de Boer G, Limburg PC, Kallenberg CG. Ann Rheum Dis; 1997 Nov; 56(11):661-6. PubMed ID: 9462168 [Abstract] [Full Text] [Related]
15. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H. Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381 [Abstract] [Full Text] [Related]
16. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Haugbro K, Nossent JC, Winkler T, Figenschau Y, Rekvig OP. Ann Rheum Dis; 2004 Apr; 63(4):386-94. PubMed ID: 15020332 [Abstract] [Full Text] [Related]
18. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases. Clarke MC, Carr R, Burdash NM, Chen ZY, Ainsworth SK. Diagn Immunol; 1986 Apr; 4(6):288-93. PubMed ID: 3545632 [Abstract] [Full Text] [Related]